Searched for
HENGRUI PHARMA
Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...- Glenmark Pharma shares in focus on $1.1 billion deal for oncology drugGlenmark Pharma shares: The company's unit Glenmark Specialty S.A. signed an exclusive licensing deal with China’s Hengrui Pharma for Trast...
- Stocks in news: Glenmark Pharma, Adani Energy, Dr Reddy's, Tata Motors, Newgen SoftwareMarkets declined due to global and domestic pressures, with the Nifty testing support at 25040. Glenmark Pharma partnered with Hengrui Phar...
- Glenmark inks pact with Hengrui Pharma for cancer therapy Trastuzumab RezetecanGlenmark Pharmaceuticals has partnered with Hengrui Pharma, securing exclusive rights to develop and commercialize Trastuzumab Rezetecan gl...
- Obesity drugs gain weight in labs: Several clinical trials by big and small pharma cos underwayDriven by the success of Wegovy and Mounjaro, numerous pharma companies are developing anti-obesity drugs, with over 170 in various stages....
- Merck nears $10 bn deal for respiratory drugmaker Verona: ReportsMerck is close to buying Verona Pharma, a biotech firm specializing in lung diseases. The deal is valued at around $10 billion. Merck aims ...
- GSK boosts respiratory portfolio with $1.4 bn Aiolos Bio dealGSK will pay $1 billion upfront and up to $400 million in certain success-based regulatory milestone payments. It will also make milestone ...
- 304% gains show Buffett-style investing now works in ChinaTo Yang, China has become a prime market for investing in quality consumer-focused companies.
Load More